Form 4: Addus HomeCare CEO Plans Option Exercise and Share Sale

Addus HomeCare Corp's Chairman and CEO, R. Dirk Allison, has filed a Form 4 detailing a planned exercise of stock options and subsequent sale of shares.

Summary

• R. Dirk Allison, Chairman and CEO of Addus HomeCare Corp (ADUS), filed a Form 4 indicating planned transactions for September 2, 2025.
• Allison plans to acquire 25,000 shares of Common Stock by exercising employee stock options at a price of $19.71 per share.
• Simultaneously, Allison plans to dispose of 25,000 shares of Common Stock through two separate sales.
• The first sale involves 20,565 shares at a weighted average price of $115.72, with prices ranging from $115.13 to $116.10.
• The second sale involves 4,435 shares at a weighted average price of $116.34, with prices ranging from $116.13 to $116.59.
• All options are fully vested, and the transactions are made pursuant to a Rule 10b5-1(c) plan.
• Following these planned transactions, Allison's direct beneficial ownership will be 166,461 shares of Common Stock.

Sentiment

Score: 7

Explanation: The CEO is realizing significant gains from long-held options, which is positive for the individual. The transaction is a pre-planned 'sell-to-cover' type under a 10b5-1 plan, which typically carries a neutral signal for the company's future prospects, as it's not a discretionary sale based on new information.

Positives

• The planned exercise of options at a strike price of $19.71 and subsequent sale at prices over $115 indicates a significant unrealized gain for the CEO, reflecting strong past performance of Addus HomeCare's stock.
• The transaction is pre-planned under a Rule 10b5-1(c) plan, which suggests it is a routine liquidity or diversification event rather than a discretionary sale based on new negative information.

Negatives

• The CEO is selling 25,000 shares, which, while offset by option exercise, represents a reduction in direct equity exposure.

Future Outlook

The filing does not provide a general future outlook for the company, but it indicates a pre-scheduled transaction under a Rule 10b5-1 plan, which is a forward-looking arrangement for insider stock transactions.

Industry Context

This filing is a routine insider transaction report and does not contain information directly related to broader industry trends or competitive landscape. It reflects an individual executive's financial planning within the home healthcare sector.

Stakeholder Impact

• Shareholders may view the pre-planned nature of the transaction as a neutral event, as it is a routine financial management activity for an executive rather than a signal of changing company fundamentals.
• The significant gain realized by the CEO from the option exercise could be seen as a positive reflection of the company's stock performance over time.

Key Dates

Recommendation

The filing details a routine, pre-planned insider transaction (exercise of options and subsequent sale of an equivalent number of shares) by the CEO under a Rule 10b5-1 plan. Such transactions are typically for personal financial planning, diversification, or tax purposes and do not usually indicate a change in the company's fundamental outlook or warrant a shift in investment recommendation. The significant profit realized by the CEO from the option exercise reflects past stock appreciation, which is positive, but the transaction itself is not a strong buy or sell signal.

Keywords

Addus HomeCare, ADUS, Insider Trading, Form 4, Stock Option Exercise, Share Sale, R. Dirk Allison, CEO, Chairman, Beneficial Ownership, 10b5-1 Plan